Ebola: ACAJ calls for audit over opaque management of allocated funds

Author: Grâce GUKAPublished on: October 24, 2026Country: Democratic Republic of the Congo

HealthCrime & Law

Ebola: ACAJ calls for audit over opaque management of allocated funds

The Association for Access to Justice (ACAJ) is asking the General Inspectorate of Finance (IGF) to audit funds allocated to the fight against Ebola in the Democratic Republic of the Congo. Its president, Georges Kapiamba, cited Africa CDC Director-General Dr Kaseya’s statement that 700 million of the 926.66 million dollars disbursed by donors could not be traced. Health Minister Samuel Roger Kamba said the funds were paid directly to international implementing partners and that the government had traced only 220 million dollars. ACAJ also welcomed 50 million dollars raised domestically and transferred to the health ministry.

Stay informed with NewsBoulevard

Get the latest news summaries delivered to your inbox

Related News

Ebola response workers strike in Nia-Nia to demand their allowances

HealthDemocratic Republic of the Congo

radiookapi.net•19m ago

Ebola response workers strike in Nia-Nia to demand their allowances

Field workers supporting the Ebola response began an indefinite strike on Friday, October 23, in the Nia-Nia health zone in Mambasa territory, Ituri. They are demanding nearly three months of unpaid allowances, which they say have not been paid since August, and have suspended all activities until they receive the full amount. Their spokesperson, Dr. Willy Ngeleza, said repeated efforts to resolve the issue with health authorities and partners had failed. The strike could disrupt disease surveillance, community outreach and infection prevention as Ebola continues to spread in health areas around Mambasa.

Ebola in DR Congo: Clinical vaccine trial launched against Bundibugyo strain

HealthScienceDemocratic Republic of the Congo

AfricaNews•2h ago

Ebola in DR Congo: Clinical vaccine trial launched against Bundibugyo strain

The first participant in the TUMAINI clinical trial was vaccinated Friday in Bunia, Ituri, as researchers began evaluating vaccines against Bundibugyo virus disease. The study is led by the National Institute for Biomedical Research and the University of Antwerp, with support from the WHO, and will assess the candidates’ safety, immunogenicity and efficacy. The first candidate is Ervebo, authorized against the Zaire strain, but its protection against Bundibugyo has not been established; candidates from Moderna and from the University of Oxford with the Serum Institute of India are also expected to join the trial. TUMAINI uses ring vaccination for high-risk contacts and was officially launched in Bunia by Ituri’s military governor, Major General Gaby Kasongo Mulumba.

Woman, 65, becomes second patient to die of Ebola in Kenya

HealthWorld / InternationalKenya

Patrick Jackson and Timothy Obiezu•2h ago

Woman, 65, becomes second patient to die of Ebola in Kenya

Kenya has recorded its second Ebola death during the country’s first outbreak of the disease. The victim, a 65-year-old woman and close relative of the first patient, died after being quarantined and developing symptoms on 13 October. Seven other people, including three relatives, three health workers and a hospital cleaner, are being treated at two isolation facilities; officials say the cases are part of one cluster, with no evidence of community spread. Kenya has stepped up screening of travellers from ten high-risk countries, while the US has warned its citizens against travelling there.

Stay Updated with NewsBoulevard

Subscribe to our newsletter for the latest news summaries delivered to your inbox